↓ Skip to main content

Cochrane Database of Systematic Reviews

Trifluoperazine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users
weibo
1 weibo user
wikipedia
4 Wikipedia pages

Readers on

mendeley
153 Mendeley
Title
Trifluoperazine for schizophrenia
Published in
Cochrane database of systematic reviews, January 2004
DOI 10.1002/14651858.cd003545.pub2
Pubmed ID
Authors

Luciana de Oliveira Marques, Bernardo Soares, Mauricio Silva de Lima

Abstract

Trifluoperazine is an inexpensive accessible 'high potency' antipsychotic drug, widely used to treat schizophrenia or related psychoses.

Timeline
X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 153 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 153 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 18%
Student > Bachelor 17 11%
Researcher 14 9%
Student > Ph. D. Student 9 6%
Student > Doctoral Student 9 6%
Other 24 16%
Unknown 53 35%
Readers by discipline Count As %
Medicine and Dentistry 34 22%
Psychology 19 12%
Nursing and Health Professions 13 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 16 10%
Unknown 57 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2020.
All research outputs
#5,829,853
of 26,731,031 outputs
Outputs from Cochrane database of systematic reviews
#7,857
of 13,270 outputs
Outputs of similar age
#18,616
of 152,595 outputs
Outputs of similar age from Cochrane database of systematic reviews
#24
of 51 outputs
Altmetric has tracked 26,731,031 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,270 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,595 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.